Expired contract
Medicines Discovery Catapult will conduct an in vivo 18F imaging and toxicity study.
Details
- Value
- GBP 76,535.54
- Topic
- Research and experimental development services
- Published
- 7 July 2022
- Source
- uk:contracts_finder
Tender description
The Medicines Discovery Catapult will conduct an in vivo 18F imaging and toxicity study in naive and cancer xenograft bearing mice of our HER2 targeting apoferritin anti-cancer drug delivery platform.
Timeline
- Completed: Award date5 May 2022
- Completed: Contract expiry date5 May 2022
- Completed: Award published7 July 2022Current notice
About the buyer
University of Nottingham is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 73100000 · Research and experimental development services
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@university-of-nottingham.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@university-of-nottingham.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@university-of-nottingham.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@university-of-nottingham.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@university-of-nottingham.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@university-of-nottingham.gov |
6 similar open tenders
See more open tenders related to Medicines Discovery Catapult will conduct an in vivo 18F imaging and toxicity study..
- Open tender
Commercial X Dynamic Market
Related buyers
Buyers similar to University of Nottingham.
BuyersCountValue
- 337£19.0m
- 267£314.1m
- 130£195.8m
- 124£173.5m
- 114£48.2m
- 112£11.7m
- 101£60.1m
- 96£55.7m
- 90£25.5m
- 84£16.0m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
